1. Home
  2. RM vs KMDA Comparison

RM vs KMDA Comparison

Compare RM & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regional Management Corp.

RM

Regional Management Corp.

HOLD

Current Price

$32.20

Market Cap

390.4M

Sector

Finance

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.92

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RM
KMDA
Founded
1987
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.4M
458.6M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
RM
KMDA
Price
$32.20
$8.92
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$30.00
$13.00
AVG Volume (30 Days)
56.6K
65.5K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
3.61%
2.21%
EPS Growth
7.49
N/A
EPS
4.45
N/A
Revenue
$645,598,000.00
N/A
Revenue This Year
$12.83
$14.79
Revenue Next Year
$7.93
$11.38
P/E Ratio
$7.47
$24.59
Revenue Growth
9.70
N/A
52 Week Low
$25.41
$5.54
52 Week High
$46.00
$9.35

Technical Indicators

Market Signals
Indicator
RM
KMDA
Relative Strength Index (RSI) 40.00 56.02
Support Level $30.85 $6.69
Resistance Level $34.89 $9.35
Average True Range (ATR) 1.44 0.27
MACD 0.05 -0.02
Stochastic Oscillator 23.47 60.00

Price Performance

Historical Comparison
RM
KMDA

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: